Medicinal Chemistry Research (MCRE) publishes papers on a wide range of topics, favoring research with significant, new, and up-to-date information. Although the journal has a demanding peer review process, MCRE still boasts rapid publication, due in part, to the length of the submissions. The journal publishes significant research on various topics, many of which emphasize the structure-activity relationships of biologically active compounds. For more information on the areas of research that MCRE publishes, please see the Instructions for Authors.
- Offers prompt publication of experimental achievements in drug design, drug discovery and mechanisms of action
- Covers chemical biological relationships, and correlations of structure with mode of action
- Increases understanding of biochemical interactions
- 97% of authors who answered a survey reported that they would definitely publish or probably publish in the journal again
- Longqin Hu
- Publishing model
- Hybrid (Transformative Journal). Learn about publishing Open Access with us
- 1.783 (2019)
- Impact factor
- 1.608 (2019)
- Five year impact factor
- 16 days
- Submission to first decision
- 88 days
- Submission to acceptance
- 256,906 (2020)
Authors (first, second and last of 11)
Design and antiproliferative and antioxidant activities of furan-based thiosemicarbazides and 1,2,4-triazoles: their structure-activity relationship and SwissADME predictions
Synthesis, characterization and anticancer evaluation of nitrogen-substituted 1-(3-aminoprop-1-ynyl)-4-hydroxyanthraquinone derivatives
Authors (first, second and last of 8)
Synthesis and antibacterial activity of novel Schiff bases of thiosemicarbazone derivatives with adamantane moiety
Authors (first, second and last of 5)
As a result of the significant disruption that is being caused by the COVID-19 pandemic we are very aware that many researchers will have difficulty in meeting the timelines associated with our peer review process during normal times. Please do let us know if you need additional time. Our systems will continue to remind you of the original timelines but we intend to be highly flexible at this time.
We are delighted to announce a special issue of Medicinal Chemistry Research honoring Prof. Grunewald, a respected teacher and a well-known and highly regarded medicinal chemist. The special issue will be guest edited by Dr. Michael Wolfe and Dr. Moorthy Palanki. We would like to invite you to submit a review or research article to this special issue under the broad theme of drug design and discovery. We aim for submission by March 1, 2021 and publication of the special issue in mid 2021.
Prof. Grunewald received his BS in Chemistry and Bachelor in Pharmacy from Washington State University in 1960 and his Ph.D in Physical Organic Chemistry working with Prof. Howard Zimmerman at University of Wisconsin, Madison in 1966. He then joined the faculty at the University of Kansas in the Department of Medicinal Chemistry where he had been until his retirement in 2018. He served as the department chair in 1994-2003 and received the Higuchi/Simons Research Achievement Award for research excellence in the biomedical sciences at the University of Kansas. He has served the Medicinal Chemistry Division of ACS in various capacities including as Vice Chair (1993), Chair (1994), Councilor (1999-2001), and as a general chair of the 27th National Medicinal Chemistry Symposium in 2000. He was inducted to the ACS Division of Medicinal Chemistry Hall of Fame in 2006 and elected as a Fellow of both the AAPS (2006) and AAAS (1992). He trained over 100 undergraduate and graduate students in his laboratory over the decades, and his trainees went on to successful careers of their own in academia, industry, and government.
Medicinal Chemistry Research is pleased to announce a special issue in honor of Prof. Robert Vince on the occasion of his 80th birthday.
The special issue will be guest edited by Dr. Zhengqiang Wang and Dr. David Ferguson. Interested authors are invited to submit a review paper or research article to this special issue under the broad theme of drug design and discovery. The deadline for submission is 1 November, 2020.
We are pleased to announce that Longqin Hu, Ph.D. is the new Editor-in-Chief of Medicinal Chemistry Research, commencing January 1st, 2020.
About this journal
- Electronic ISSN
- Print ISSN
- Abstracted and indexed in
- BFI List
- Biological Abstracts
- CAB Abstracts
- Chemical Abstracts Service (CAS)
- Current Contents/ Life Sciences
- EBSCO Discovery Service
- Google Scholar
- INIS Atomindex
- Institute of Scientific and Technical Information of China
- Japanese Science and Technology Agency (JST)
- Journal Citation Reports/Science Edition
- Norwegian Register for Scientific Journals and Series
- OCLC WorldCat Discovery Service
- ProQuest Central
- ProQuest Materials Science and Engineering Database
- ProQuest SciTech Premium Collection
- ProQuest Technology Collection
- ProQuest-ExLibris Primo
- ProQuest-ExLibris Summon
- Science Citation Index Expanded (SciSearch)
- TD Net Discovery Service
- UGC-CARE List (India)